This topic contains a solution. Click here to go to the answer

Author Question: When it comes to external secondary data, which of the following statements if FALSE? a. Most people ... (Read 131 times)

armygirl

  • Hero Member
  • *****
  • Posts: 556
When it comes to external secondary data, which of the following statements if FALSE?
 a. Most people underestimate what is available.
  b. There is likely to be relevant external secondary data on almost any problem.
  c. The fundamental problem with relevant external secondary data is availability
  d. The fundamental problem with relevant external secondary data is identifying and accessing what is there.
  e. Researchers who know how much valuable secondary data exists may not know how to find it.

Question 2

Wilbur never thought much about toothpaste, but he regularly bought Bright White and Sharp Tooth brands. Most likely, Wilbur's attitude toward these brands was based on
 a. support arguments rather than counterarguments.
  b. persuasive arguments.
  c. source derogations.
  d. counterarguments rather than support arguments.
  e. a few simple beliefs.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

lorealeza77

  • Sr. Member
  • ****
  • Posts: 356
Answer to Question 1

c

Answer to Question 2

E




armygirl

  • Member
  • Posts: 556
Reply 2 on: Jun 28, 2018
Gracias!


ashely1112

  • Member
  • Posts: 347
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Aspirin may benefit 11 different cancers, including those of the colon, pancreas, lungs, prostate, breasts, and leukemia.

Did you know?

Anti-aging claims should not ever be believed. There is no supplement, medication, or any other substance that has been proven to slow or stop the aging process.

Did you know?

More than 4.4billion prescriptions were dispensed within the United States in 2016.

Did you know?

Your heart beats over 36 million times a year.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library